Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2016 Jun 2;6:26975. doi: 10.1038/srep26975

Erythrocyte intracellular Mg2+ concentration as an index of recognition and memory

Wenxiang Xiong 1, Yaru Liang 1, Xue Li 1, Guosong Liu 1, Zhao Wang 1,a
PMCID: PMC4890594  PMID: 27253451

Abstract

Magnesium (Mg2+) plays an important role in the neural system, and yet scarcely any research has quantitatively analyzed the link between endogenous Mg2+ level and memory. Using our original technique, we measured erythrocyte intracellular ionized Mg2+ concentration (RBC [Mg2+]i), which linearly correlated to recognition and spatial memory in normal aging rats. In the brain, RBC [Mg2+]i significantly correlated to hippocampus extracellular fluid Mg2+ concentration, and further correlated to hippocampal synapse density. Elevation of Mg2+ intake in aged rats demonstrated an association between RBC [Mg2+]i increase and memory recovery. The therapeutic effect of Mg2+ administration was inversely correlated to individual basal RBC [Mg2+]i. In summary, we provide a method to measure RBC [Mg2+]i, an ideal indicator of body Mg2+ level. RBC [Mg2+]i represents rodent memory performance in our study, and might further serve as a potential biomarker for clinical differential diagnosis and precise treatment of Mg2+-deficiency-associated memory decline during aging.


Magnesium (Mg2+) is the fourth most abundant ion in the body and the second most abundant ion in the cells. Mg2+ is a cofactor for more than 300 enzymatic reactions, responsible for conducting biomolecule synthesis/hydrolysis, signal transmission, and gene expression. It also binds to ATP to maintain its stability, and is therefore essential for energy metabolism. Mg2+ participates in important vital activities, such as cell proliferation, neuron spiking, and muscle contraction/relaxation, among others1,2,3,4,5.

In the neural system, Mg2+ also plays important roles. It competes with calcium (Ca2+) to mediate N-methyl-D-aspartic acid receptor (NMDAR)-dependent neural activity. Although Mg2+ blocks NMDAR at resting membrane potential, our previous study showed that, chronic elevation of Mg2+ level in hippocampal neuron culture medium upregulated NMDAR signal transmission and enhances synaptic plasticity6. In our follow-up study, oral administration of magnesium-L-threonate (MgT) to aged rats recovered their behavioral impairments7. These findings suggest a crucial role for Mg2+ in brain function. However, our previous in vivo studies did not show any difference of endogenous Mg2+ level between young and aged rats. That means, although exogenous Mg2+ administration showed notable therapeutic effects on the memory recovery of aged rats, it was still not clear whether the memory impairment during aging was caused by endogenous Mg2+ level changes or not. In fact, all the figures which involved in the therapeutic effect of Mg2+ supply enhancement, whatever on the behavioral, cellular or molecular level, lack support of endogenous Mg2+ data7. It only reported a slight increase in the Mg2+ concentration of the cerebrospinal fluid (CSF [Mg2+]) after Mg2+ administration, in an independent experiment of exogenous Mg2+ delivery optimization. Yet, the evidence was far from enough. It requests further studies on the relationship between endogenous Mg2+ status and memory performance.

To find an ideal Mg2+ marker for brain function and memory is a challenging task. Many Mg pools in the body could serve as potential candidates. The total Mg content in an adult human is about 1 mol: 60~65% of it is contained in the skeleton, 27% in skeletal muscle, 6~7% in other tissues, and 1% in extracellular fluid1. In cells, most of the Mg is bound to biomolecules, leaving about 10% as the free ionized form. Previous research has assessed Mg content (ionized and/or non-ionized) in different tissues using various techniques (Supplementary Tables S1 and S2). Unfortunately, many of the potential candidates showed no response to physiological and pathological processing, and therefore could not function as indicators. A few of others had a very limited applicable range. By contrast, RBC [Mg2+]i was found to be a potential Mg2+ index, which effectively represents body Mg2+ loss in the cases of hypertension and/or diabetes8,9,10,11,12, which led us to focus on the RBC [Mg2+]i to study its capability as a body Mg2+ marker.

Aging was also associated with RBC [Mg2+]i decline8. The age related body Mg2+ deficiency may be caused by unhealthy dietary pattern13,14, abnormal Mg2+ absorbance/clearance function15,16,17,18, insulin resistance and metabolic syndrome10,19,20, and abnormal hormone secretion21,22. On the other hand, aging was a predictor for memory loss23,24,25,26,27, while compensation of Mg2+ intake could rescue cognitive function in aged animals7. These evidences led us to hypothesize that the age related RBC [Mg2+]i decline might correspond with memory impairment during aging. Therefore, we used aging rats as a model to research whether RBC [Mg2+]i could be a potential memory indicator.

In the present study, we found and confirmed a significant correlation between RBC [Mg2+]i and memory performance in aged rats. The level of RBC [Mg2+]i directly influenced memory status, when the supply of exogenous Mg2+ was changed in aged rats. The effect of abundant Mg2+ supply to improve memory was inversely correlated to the individual basal RBC [Mg2+]i in aged rats.

Results

RBC [Mg2+]i indicates body Mg2+ loss

For the purpose of studying the correlation between Mg2+ and memory, we first evaluated the possibility that RBC [Mg2+]i could act as an indicator for body Mg2+ status. Mg2+ intake deficiency was an ideal model for creating a dramatic Mg2+ change in a short term. The Mg2+ content in the blood, tissue, and skeleton has shown a decline in this model28,29,30,31,32,33. We postulated that if RBC [Mg2+]i was also a body Mg2+ marker, it would respond to food Mg2+ restriction too.

Feeding the rats with Mg2+ deficient food caused a dramatic drop in total Mg intake, from 22.5 ± 3.62 to 3.16 ± 0.56 mg/day (p < 0.001; Fig. 1a). A negative value of body Mg retention was found (see Supplementary Fig. S1), indicating a body Mg2+ loss. For our interest, the RBC [Mg2+]i significantly decreased in the Mg2+ restriction group, comparing to the normal Mg2+ group (0.14 ± 0.025 vs. 0.24 ± 0.026 mmol/L, p < 0.001; Fig. 1b). In other endogenous Mg2+ compartments, the total Mg in soft tissues showed changes of less than 7% (Equation (1)) after Mg2+ restriction. The skeletal total Mg, which represented the largest exchangeable Mg2+ pool in the body, showed a 24.68% decline. The CSF [Mg2+] showed a 27.36% decline, which was similar to the RBC [Mg2+]i (a 31.05% decline, Fig. 1c). These results in tissue Mg2+ pool agreed with previous reports28,29,30,31,32,33.

Figure 1. RBC [Mg2+]i indicates body Mg2+ decline.

Figure 1

(a) Daily Mg2+ intake in normal and low Mg2+ diet groups. (b) RBC [Mg2+]i in normal and low Mg2+ diet groups. (c) Percentage changes of Mg (Mg2+ or total Mg) in tissues, cerebrospinal fluid (CSF), and erythrocytes (RBCs) (calculation was described in Equation (1)). Young rats (3 months), n = 10 for each group. Unpaired t test, ***p < 0.001.

Therefore, we concluded that RBC [Mg2+]i could serve as a body Mg2+ marker in rats, which sufficiently indicated the body Mg2+ decline. The similar changes in scale seen for CSF [Mg2+] and RBC [Mg2+]i supported a potential ability of RBC [Mg2+]i to represent brain Mg2+ levels.

Aging-associated RBC [Mg2+]i loss correlates to memory decline

Our next task was to assess whether RBC [Mg2+]i, our selected endogenous body Mg2+ marker, would show any direct relationship with memory performance. Aging is known as a physiological process that induces both body Mg2+ deficiency and memory decline. We studied whether RBC [Mg2+]i level and memory status correspond to each other during aging, by assessing behavioral performance and RBC [Mg2+]i level in young and aged rats.

In the novel object recognition test (NORT), aged animals showed a significant decrease in recognition score comparing to young group, (p < 0.001; Fig. 2a). The aged rats had a greater variation: not all aged animals had memory decline; some individuals retained equal memory to that seen in the young rats. The RBC [Mg2+]i levels were significantly lower in aged rats (p < 0.001; Fig. 2a), indicating a body Mg2+ decline during aging. The variation in individual RBC [Mg2+]i levels showed a similar pattern to that seen for the recognition index.

Figure 2. Correlation analysis between RBC [Mg2+]i and recognition memory in young and aged rats.

Figure 2

(a) The novel object recognition test (NORT) recognition index (left) and RBC [Mg2+]i (right) of young (3 months) and aged (22 months) rats. (b) Linear correlation between RBC [Mg2+]i and recognition index in young and aged rats. n = 14 for each group. Unpaired t test, ***p < 0.001.

In addition to conducting an intergroup comparison, we also performed a correlation study between individual RBC [Mg2+]i and memory in a single group. The RBC [Mg2+]i not only corresponded with the recognition index between young and aged groups, but also showed a significant linear correlation with the recognition index in aged individuals (Fig. 2b). It implied that, the value of endogenous Mg2+ could represent individual memory: a lower RBC [Mg2+]i, would indicate a more forgetful aged individual. The correlation between RBC [Mg2+]i and recognition index was not significant in the young rats. One explanation for this result might be the lesser dispersion of both the RBC [Mg2+]i and recognition index in the young group, which made the data ineffective for a intra-group correlation study.

The correlation between RBC [Mg2+]i and spatial working memory was examined by T-maze test in young and aged rats, in order to confirm the correlation studies above. The difficulty of the T-maze task depended on the retention interval between the sample run and the choice run. An extension in the interval was associated with a decrease in the correct choice rate in both rat groups. A significant difference was noticed between the young and aged rats at an 8 minute interval (Fig. 3a). Thus, we chose 8 minutes as the optimized delay interval to conduct subsequent experiments. The same animals used in the NORT experiment were used for the T-maze test here. The RBC [Mg2+]i levels of these rats have already been shown in Fig. 2, so we did not illustrate them again.

Figure 3. Correlation analysis between RBC [Mg2+]i and spatial memory in young and aged rats.

Figure 3

(a) The T-maze correct choice rate of young and aged rats with different retention intervals. Two-way ANOVA followed by Bonferroni’s post hoc test, *p < 0.05. (b) The T-maze correct choice rate of young and aged rats with 8 minutes’ retention. Unpaired t test, *p < 0.05. (c) Linear correlation between RBC [Mg2+]i and T-maze correct choice rate (8 minutes retention) in young and aged rats. (The same animals as in Fig. 2 were used).

The young rats performed better than aged rats in the 8 minute T-maze test (Fig. 3b). A linear correlation was observed between RBC [Mg2+]i and the correct choice rate in the young rats (Fig. 3c), and the correlation was much stronger in the aged rats (R2 = 0.64, p = 0.0006).

Again, RBC [Mg2+]i and memory appeared to have a tight connection. RBC [Mg2+]i was positively correlated with recognition memory as well as spatial working memory in aged animals, indicating that the RBC [Mg2+]i might be used to predict memory performance during aging. Aging caused widespread distributions in both RBC [Mg2+]i and behavioral performance (Figs 2a and 3b). It revealed that only “being old” did not strictly indicate memory decline, while the decrease in RBC [Mg2+]i rigidly matched the memory deficiency.

Exogenous compensation of RBC [Mg2+]i recovers memory decline in aged rats

According to above results, we confirmed the correspondence between the degenerations of RBC [Mg2+]i and memory performance during aging. However, the causality of whether the metabolism of RBC [Mg2+]i could directly influenced the memory function, or if the memory decline caused the RBC [Mg2+]i loss, was still unknown. Our following research was aimed at answering this question. Exogenous Mg2+ supplement was used to artificially regulate the RBC [Mg2+]i level. We were interested in, if this treatment might alter animals’ behavioral performance and if the correlation would still exist.

A previous study reported that 24 days administration of magnesium-L-threonate (MgT), a highly bioavailable Mg2+ compound, could increase the daily Mg2+ intake in aged rats, and elevate the CSF [Mg2+]7. Here, we also used MgT to regulated the RBC [Mg2+]i level. Figure 4a shows the procedure of the experiment conducted in the present study. The RBC [Mg2+]i and T-maze test were assessed prior to MgT administration (basal level), and then MgT was administered from week 0 to week 4 (Mg2+ on). From week 4 to week 5, a secondary measurement of RBC [Mg2+]i and a second T-maze test were conducted. This was followed by 4 weeks of normal Mg2+ intake to allow the body Mg2+ to return to normal level (Mg2+ off). At week 9, we did a final correlation test to study the effect of MgT withdrawal.

Figure 4. Adjustment of RBC [Mg2+]i by exogenous Mg2+ supplementation could influence spatial memory.

Figure 4

(a) Procedure for the “on/off” administration of exogenous Mg2+ treatment (aged rats, n = 14). (b,c) Changes in RBC [Mg2+]i and T-maze correct choice rate (8 minutes) during Mg2+ “on/off” periods. One-way ANOVA, RBC [Mg2+]i, F2,39 = 27.31, p < 0.0001; T-maze, F2,39 = 8.94, p = 0.0006. ANOVA was followed by Bonferroni’s post hoc test, **p < 0.01, ***p < 0.001. (d) Inverse linear correlation between basal RBC [Mg2+]i and ΔRBC [Mg2+]i (RBC [Mg2+]i, on − RBC [Mg2+]i, basal). (e) Inverse linear correlation between basal RBC [Mg2+]i and ΔT-maze correct choice rate (T-mazeon - T-mazebasal). (f) Linear correlation between RBC [Mg2+]i and T-maze correct choice rate during Mg2+ “on/off”.

The exogenous Mg2+ treatment successfully improved both RBC [Mg2+]i (Fig. 4b) and T-maze correct choice rate (Fig. 4c). Withdrawal of supplementary Mg2+ resulted in a return to the basal level for both measurements, so that an “on/off” pattern was evident. Notably, during MgT administration, not all rats shared a similar scale of increases in RBC [Mg2+]i or memory, but only the individuals with low basal RBC [Mg2+]i levels made remarkable changes. While the smarter rats showed weaker effects of Mg2+ administration (as shown in Supplementary Fig. S2). An inverse correlations was evident between the basal value of RBC [Mg2+]i and Δ value of RBC [Mg2+]i/memory (Fig. 4d,e). This suggested a possible threshold for Mg2+ therapy: exogenous Mg2+ intervention might selectively affect forgetful individuals to a greater extent. The various therapeutic effects of MgT might depend on the different responses of body Mg retention (Supplementary Fig. S3), which would recruit Mg2+ in low basal RBC [Mg2+]i rats while preventing excessive Mg2+ absorbance in normal basal RBC [Mg2+]i rats.

Strong intra-group correlations were evident between RBC [Mg2+]i and spatial working memory at both the Mg2+basal and Mg2+off periods (Fig. 4f). The correlation during Mg2+on was weak because abundant Mg intake narrowed the deviation among the individuals. In addition, a saturation seemed to show for the effect of Mg2+ administration on memory enhancement.

In conclusion, RBC [Mg2+]i and memory remained correlated with each other during RBC [Mg2+]i regulation, which highlighted the connection between these two items. Elevating the RBC [Mg2+]i through exogenous Mg2+ administration successfully rescued the memory decline of aged rats, which suggested the subjective effect of body Mg2+ status (presented by RBC [Mg2+]i) to influence animal memory. The memory recovery effect was more pronounced in individuals with lower basal RBC [Mg2+]i levels, indicating the function of RBC [Mg2+]i to predict therapeutic effect of Mg2+ compensation during aging.

The correlation between RBC [Mg2+]i and memory was mediated by brain Mg2+ level

We next tried to clarify the mechanism underlying the correlation between RBC [Mg2+]i and memory. The same group of aged rats was used as in Figs 2~4. Modification of the extracellular [Mg2+] was previously reported to affect the function of hippocampal neuron culture6. In our present research, the Mg2+ concentration in hippocampal extracellular fluid (Hip ECF [Mg2+]) was significantly correlated with the RBC [Mg2+]i in aged rats (Fig. 5a). The ECF [Mg2+], in turn, was significantly correlated with T-maze performance (Fig. 5b).

Figure 5. Correlation between RBC [Mg2+]i and brain Mg2+.

Figure 5

(a) Linear correlation between RBC [Mg2+]i and hippocampus extracellular fluid Mg2+ concentration (Hip ECF [Mg2+]). (b) Linear correlation between Hip ECF [Mg2+] and T-maze correct choice rate (data at Mg2+ off, Fig. 4).

The correlation between RBC [Mg2+]i and CSF [Mg2+] was not significant in aged rats (Supplementary Fig. S4a); however, dividing the rats into normal and low groups, according to their RBC [Mg2+]i values (dotted line in Supplementary Fig. S4a), revealed a significant intergroup difference in the CSF [Mg2+] level (Supplementary Fig. S4b, right).

These data revealed a link between peripheral Mg2+ and CNS Mg2+ (also shown in Fig. 1c). An exchange of Mg2+ apparently occurred between the brain and periphery through the whole body blood circulation. The metabolism of body Mg2+ pool would therefore affect both the ECF [Mg2+] and RBC [Mg2+]i, thereby contributing to the observed correlation. Although the Hip ECF [Mg2+] could more accurately represent the Mg2+ status in the functional brain region, the RBC [Mg2+]i is much easier to obtain and safer to assess.

Correlations among RBC [Mg2+]i, Hip ECF [Mg2+], synapse density, and memory

The synapse is the basic unit for building the neural network. Previous work showed that synaptic density in the hippocampus, which showed an increase by Mg2+ oral administration, was significantly correlated with memory performance7. Therefore, we examined whether the RBC [Mg2+]i, which indicated the memory function, would also be correlated with the synapse density in aged rats.

Immunostaining of synaptophysin was used to identify presynaptic terminus. The density of synaptophysin-positive (Syn-(+)) puncta was used to evaluate synapse density. A strong correlation between RBC [Mg2+]i and Syn-(+) puncta density was found in the dentate gyrus (DG) subregion of Hip (Fig. 6a), as well as in the PrL subregion of medial prefrontal cortex (mPFC, Fig. 6b). Figure 6c,d show the statistical heat maps of the linear correlation analysis for all the items, arranged in a logical sequence from peripheral Mg2+ (RBC [Mg2+]i), brain Mg2+ (Hip ECF [Mg2+]), and synapse density (8 different brain subregions), to memory performance (NORT and T-maze). The dark brown squares indicate the strongest correlations. Synapse densities in the dorsal and lateral striatum were used as controls, which showed no significant correlation with almost any of the other items.

Figure 6. Correlation between RBC [Mg2+]i, Hip ECF [Mg2+] and Syn-(+) punctal density.

Figure 6

(a) Linear correlation between the RBC [Mg2+]i and Syn-(+) puncta density in dentate gyrus (DG) subregion of Hip (aged rats, n = 14). The density was estimated as the number of immunostained puncta per μm2 (#/μm2). Rat #1 (blue circle) and rat #2 (red circle) were selected; their immunostaining images were showed as examples. (b) Linear correlation between the RBC [Mg2+]i and Syn-(+) puncta density in the PrL subregion of the prefrontal cortex (PFC). The immunostaining images of rat #1 and rat #2 were showed as examples. (c,d) Heat maps of linear analysis for [Mg2+], Syn-(+) puncta density, and memory (c, R2; d, p).

Discussion

In the present work, for the first time, we found that endogenous Mg2+ level, which was represented by the RBC [Mg2+]i, was correlated with recognition memory and spatial memory in rats. The possible mechanism for this phenomenon was: the RBC [Mg2+]i represented the brain ECF [Mg2+] level, the latter affected the density of Syn-(+) puncta and ultimately regulated memory. We also confirmed the aging associated endogenous Mg2+ deficiency, and found that compensation of RBC [Mg2+]i deficiency by exogenous Mg2+ administration rescued the memory decline in aged rats. The Mg2+ administration selectively improved the memory of individuals with low basal RBC [Mg2+]i, showing an inverse correlation between basal RBC [Mg2+]i level and therapeutic effect. Our original technique for RBC [Mg2+]i measurement may provide a potential tool for clinical diagnosis and treatment of aging-associated memory decline.

Before the correlation studies, we established a screening protocol to provide an ideal Mg2+ index to indicate body Mg2+ status. Our focus on the blood Mg2+ pool has many advantages. First, blood samples are very easy to collect, causing little hurt to animals, allowing real time and repeated assays. Second, blood regulates the Mg2+ content in tissues of the whole body through Mg2+ exchange, which raises the possibility that blood [Mg2+] could represent the Mg2+ levels in other tissues. Third, the role of blood Mg2+ as a biomarker in peripheral diseases is well established. Some reports have already shown significant changes in blood Mg2+ pools in hypertension and diabetes patients (Supplementary Table S2).

Blood Mg2+ exists in different compartments, which consists of plasma, erythrocytes, leukocytes, and thrombocytes. Plasma [Mg2+], the extracellular Mg2+ pool, was not sufficient to represent Mg2+ decrease in metabolic syndrome (Supplementary Table S2), and failed to reflect brain [Mg2+] level34,35. Among the intracellular Mg2+ compartments, erythrocytes make up more than 90% of the total blood cells, therefore mainly affect the intracellular blood Mg2+ content. Within erythrocytes, 90% of the Mg2+ binds to biomolecules, leaving about 10% in ionized form. This free Mg2+ ([Mg2+]i) is the real Mg2+ component with the most bioactivity, which regulates intracellular physiological reactions and exchanges Mg2+ content with extracellular plasma pool. Thus, the [Mg2+]i of erythrocytes might represent the Mg2+ status of blood cells and might further correlate with the body Mg2+ status.

It has been previously reported that RBC [Mg2+]i corresponded to other blood Mg2+ pools during body Mg2+ decline in the processing of hypertension/diabetes8,9,10,11,12. In our studies, the RBC [Mg2+]i not only correlated to the Mg2+ levels in peripheral tissues, but also correlated to brain ECF [Mg2+]. A further correlation between RBC [Mg2+]i and memory was found, which still persisted when RBC [Mg2+]i was adjusted by Mg2+ intake “on/off”. Our findings redefined the biomarker function of RBC [Mg2+]i: not only being a Mg2+ marker in the periphery, but also being a memory indicator in the CNS.

Synapse is the elementary unit to build the neural network. The number of synapses determines the computational capability of a neural system, further regulates the memory function. Animal and human studies have shown strong correlations between synapse density and memory performance during normal aging36,37,38. Our previous research demonstrated that chronic Mg2+ treatment enhanced synapse density as well as memory functions in aged rats7. One of the crucial Mg2+ functions to regulate synapse density is through interaction with NMDAR. In brain, Mg2+ binds to NMDAR as a voltage-gated regulator. It inhibits background NMDAR transmission and Ca2+ influx, without further blocking burst input7. Frequent background Ca2+ influx may activate some neural inhibitory factors (calcineurin, e.g.) and downregulate NMDAR transmission39,40. While chronic suppression of background Ca2+ influx by physiological level Mg2+ (burst stimulus was not inhibited) could lead to: enhancement of NMDAR (especially NR2B subunit) signaling and CaMKII/CREB/BDNF pathway, increasing of synaptic protein expression, elevation of synapse density and reconfiguration of synaptic networks6,7,41. Meanwhile, in the aspect of energy supply, intracellular Mg2+ could regulate the function of mitochondria and increase ATP, thus also facilitates the expression and trafficking of synaptic protein42.

During aging, Mg2+ deficiency may attenuate its prevention function from over-excitation of NMDAR by background input, which would result in cascaded negative effect as: persistent increase of intracellular Ca2+ level, abnormalities of Ca2+-related signal pathway and mitochondria function, decreasing of synaptic protein expression, decline of synaptic plasticity and synapse density, and finally deficiency of cognitive function43,44,45,46.

Although above evidences suggested a possible function of brain Mg2+ to regulate synapse density in vivo, no previous analysis of endogenous Mg2+ level could support this hypothesis. In the present work, we have provided the first quantitative analysis of the relationship between brain Mg2+ level and the synapse density in the hippocampus (Fig. 6c,d). The Hip ECF [Mg2+] was significantly correlated with the density of Syn-(+) puncta in different subregions of the Hip, with the strongest correlation found in the DG. The synapse density in the DG was further correlated with the recognition and spatial memory, in agreement with earlier work7,38.

The mPFC also plays an important role in learning and memory. The synapse density in the PrL subregion was the most strongly correlated with memory. The striatum was reported to influence the transformation of space/response acquisition strategy in the T-maze test47, which was not found in our experiment. So striatum was used as a control in the present work. We found no correlations between synapse density of the striatum and the T-maze score (Fig. 6c,d).

With above findings, we have constructed a logical model (Fig. 7). The RBC [Mg2+]i, ECF [Mg2+], synapse density, and memory are correlated with each other. The blood and brain ECF exchange Mg2+ through the BBB. While the brain ECF [Mg2+] regulates synapse density in the Hip and mPFC functional regions, further modulating recognition and spatial memory functions. During aging, a degenerated Mg2+ metabolism from the periphery to the brain leads to downregulation of synapse density and impairment of memory. Exogenous administration of Mg2+ could rescue these symptoms. The utilization of RBC [Mg2+]i assay provides an easy, repeatable, and representative technique in the fundamental research for studying the role of Mg2+ in neural activity and memory function.

Figure 7. Model of the correlation among periphery Mg2+, brain Mg2+, synapse density, and memory.

Figure 7

In the normal condition, RBC [Mg2+]i is regulated by exogenous dietary Mg2+ intake and urine Mg2+ excretion. RBC [Mg2+]i represents the status of blood Mg2+. Mg2+ is exchanged between the blood and other tissue in periphery and between the blood and brain ECF through the blood brain barrier (BBB). The brain ECF [Mg2+] regulates synapse density in the Hip and PFC, further modulating memory function. During aging, abnormal metabolism of Mg2+ between the body and the external environment leads to a decline in RBC [Mg2+]i, which influences ECF [Mg2+] and further impairs memory. Enhancing Mg2+ intake through diet and/or drugs could affect the metabolic balance of body Mg2+ and rescue the degeneration of memory function.

The exogenous Mg2+ supplementation experiments in aged rats showed that RBC [Mg2+]i and memory corresponded with each other during the Mg2+ “on/off” periods, which highlighted the correlation between these two items. Modification of the body Mg2+ status directly affected the behavioral score, which suggested not only the associated relationship, but also the subjective role of the endogenous Mg2+ level to influence memory. This finding may help in clinical studies of the Mg2+ therapy for preventing endogenous Mg2+-deficiency-associated memory decline during aging.

Interestingly, we noticed that elevating the Mg2+ intake sufficiently rescued the memory decline in individuals with low basal RBC [Mg2+]i, whereas aged rats with normal baseline RBC [Mg2+]i levels were not affected. This finding reflects two facts. The first is, not all aged animals have endogenous Mg2+ losses and memory decline. Aging is not stringently corresponding to the degeneration of memory function, but only increases the risk; while RBC [Mg2+]i, at least on our experimental platform, shows a strict correspondence with memory performance, making itself a more precise memory indicator. From this perspective, in the studies of aging associated memory decline, it is not enough to define “aging” with only “how many years old the subject is”; but a differentiation of the individual RBC [Mg2+]i levels is also required. Using “Mg2+ age” to delimit “aging” and memory deficit is more representative (Supplementary Fig. S5). Secondly, the phenomenon of Mg2+ supplement “on/off” also suggests a characteristic of the Mg2+ medicinal value: Mg2+ treatment may selectively recover the memory of forgetful individuals to a normal level, without further influencing normal individuals to be “smarter”, according to their RBC [Mg2+]i levels. This reveals the function of “Mg2+ age” measurement to conduct the precise medication for memory decline subjects. There is an inverse correlation between the therapeutic memory improvement and basal RBC [Mg2+]i. Old individuals with normal “Mg2+ age” may not need Mg2+ compensation, while patients with low “Mg2+ age” do.

Aging-associated Mg2+ declines have already been revealed in humans8,48. Insufficient Mg2+ intake might lead to more serious Mg2+ loss and faster impairment of memory in aging people. Some surveys indicated the lack of Mg2+ intake in a significant portion of the population in industrialized countries. For example, more than 60% of Americans did not meet the RDA-DRI criteria for daily Mg2+ intake49; while average Mg2+ intake in the aging population declined to one half of the RDA14. RBC [Mg2+]i, which accurately represents body Mg2+ status, might therefore serve as an ideal clinical biomarker for Mg2+ deficiency diagnosis and Mg2+ compensation therapies. The distinction between aged people with normal “Mg2+ age” and pathological “Mg2+ age” allows individualized Mg2+ administration in the clinical setting. As looking forward, our research may provide an easy and feasible therapeutic solution for precision medicine of endogenous Mg2+-deficiency-induced memory decline in aging humans.

Methods and Materials

Experimental animals

Male Sprague-Dawley rats were obtained from Vital River Laboratory (Animal Technology Co. Ltd., Beijing, China). All animals were housed individually, with free access to standard food and water, in a controlled environment (temperature 21 ± 1 °C, humidity 50 ± 10%), under a 12:12 hour inverted light-dark cycle (light off from 8:00 A.M. to 8:00 P.M.). On arrival and during the whole experiment process, rats were fed a commercial pelleted diet (SLAC Laboratory Animal Co. Ltd, Shanghai, China), containing a normal Mg2+ concentration (0.15%). For Mg2+ intake deficiency experiment, 3-month-old rats were used (n = 10). For other experiments, young (3 month) and aged (22 month) rats were used (n = 14/group).

All experiments involving animals were approved by the Tsinghua University committees on animal care. All the methods were carried out in accordance with the approved guidelines and regulations.

Mg2+ intake deficiency

The Mg2+ deficient diet (Chinese Academy of Agricultural Sciences, Beijing, China) was composed of 180 g/kg casein, 100 g/kg sucrose, 588 g/kg cornstarch, 30 g/kg α-cellulose, 50 g/kg soybean oil, 2 g/kg methionine, 40 g/kg mineral mix, and 10 g/kg vitamin mix. The total elemental Mg2+ concentration in the Mg2+ deficient food was 0.003% (compared to 0.15% in standard diet), as determined by inductively coupled plasma atomic emission spectrometry (ICP-AES, Chinese Academy of Agricultural Sciences).

For the Mg2+ intake deficiency test, two groups of rats were fed with either standard food or Mg2+ deficient food for 4 weeks. Rat chow was weighed to calculate the daily total Mg intake. A body Mg retention test was also assessed during this period (see Supplementary Information). At the end of week 4, blood samples were taken for RBC [Mg2+]i determinations, then all animals were sacrificed, the tissues, and skeletons were taken for total Mg measurements, CSFs were taken for CSF [Mg2+] survey.

Mg2+ measurement

We designed an original technique for RBC [Mg2+]i determination. Blood was taken from the caudal vein of rat and transferred into heparin coated tube. The whole blood sample was diluted 1:1200 in Hanks Balanced Salts (HBSS, without Ca2+ and Mg2+, Sigma-Aldrich) containing 0.5 mmol/L Mg2+. A cell-permeable Mg2+ dye, Magnesium Green (MaG, exmax  =  506 nm, emmax = 531 nm, Invitrogen), was used to detect RBC intracellular free Mg2+, with a working concentration of 5 mg/L. Pluronic F-127 (Invitrogen) was used to aid dissolution of MaG. The mixture of RBCs and MaG was incubated at 37 °C for 60 minutes, washed twice, and incubated at 37 °C for another 30 minutes. The fluorescence signal was detected by flow cytometry (BD FACSCalibur). The erythrocyte population was gated by forward scatter (FSC)/side scatter (SSC) dotted diagram. A total of 1 × 104 erythrocytes in FL1 were selected for average fluorescence intensity (Supplementary Fig. S6). For calibration, parallel samples were washed twice with HBSS (zero Mg2+) and then mixed in HBSS with a gradient of [Mg2+]. A23187 (Sigma-Aldrich) was used to maintain the external and internal [Mg2+] balance across the cellular membrane, with a working concentration of 25 μmol/L. Mixtures were incubated at 37 °C for 2 hours and then analyzed by flow cytometry. A fitted curve was built using fluorescence intensity as x-axis and standard [Mg2+] gradient as y-axis (Supplementary Fig. S7a). Similar as [Mg2+]i calibration, the influence of different [Ca2+]i (with fixed [Mg2+]i = 0.25mM) to MaG fluorescence was also evaluated (Supplementary Fig. S7b). There was no influence of [Ca2+] change at basal level.

For tissular total Mg determination, the rats were anesthetized, and sacrificed by decollation. The hearts, kidneys, muscles, livers, brains, intestines, and femurs were harvested, dried and weighed. The dry samples were analyzed using inductively coupled plasma mass spectrometry (ICP-MS, General Research Institute for Nonferrous Metals, Beijing, China). Data were analyzed by dividing the tissular total Mg of each rat in low Mg diet group with average tissular total Mg in normal Mg diet group, as below:

graphic file with name srep26975-m1.jpg

For determination of CSF [Mg2+], rats were anesthetized with chloral hydrate (300 mg/kg, i.p.) and CSF was collected from the cisterna magna using a 1 mL syringe. The Mg2+ level in CSF was determined by calmagite chromometry50.

For determination of extracellular fluid (ECF) [Mg2+], rats were anesthetized with chloral hydrate (300 mg/kg, i.p.) and positioned onto a stereotaxic apparatus. A midline incision of the skull was executed and a small hole was made in the skull using a dental driller. A microdialysis guide cannula (CMA) was implanted into hippocampus (AP −5.2 mm, L −3.0 mm, V −4.2 mm). The guide cannula was fixed with light-solid dental cement. The rats were allowed to recover for 1 week before in vivo microdialysis sampling. During sampling, a microdialysis probe (CMA, dialysis length, 2 mm; OD, 0.5 mm) was inserted into the guide cannula in anesthetized rat. Artificial CSF solution (aCSF) was perfused at a flow rate of 0.2 μL/minute, for at least 30 minutes for equilibration. Samples were continuously collected for 2 hours on ice. The Mg2+ level in the ECF was determined by calmagite chromometry.

Novel object recognition test

The novel object recognition test (NORT) was used to evaluate the recognition memory of young and aged rats. The apparatus consisted of a square arena (60 × 60 × 40 cm) constructed from polyvinyl chloride, with black walls and floor. An overhead camera and a video recorder were used to monitor and record the animal’s behavior for subsequent analysis. The protocol of NORT was optimized to expand the dispersion of individuals for a better correlation study, while it could still distinguish the difference between young and aged animals (see Results 3.2).

Two days before the experiment, rats received two sessions of habituation to the arena and test room for 10 minutes/session/day. On the third day, each rat was placed in the box and exposed to 3 different objects for 5 minutes (sample phase), and then returned to its cage. The box and objects were cleaned between trials to prevent the buildup of olfactory cues. The number of times that the rats explored each object was then counted. Twenty-four hours later, the object with the maximum number of counts, which differed for each rat, was replaced with a novel object. The rat was then placed back in the box for another 5 minutes (acquisition phase). The recognition index was calculated as the percentage ratio of counts on the novel object over the total counts during the acquisition phase. There were no differences in the motor abilities, explorative abilities and object preference (rats explore one object much more/less than the other objects in the sample phase) between young and aged rats (see Supplementary Fig. S8).

T-maze test

Spatial working memory was assessed using a T-maze task in young and aged rats. Briefly, rats were maintained on a restricted feeding schedule at 85% of their free-feeding weight. The maze was located 1 m above the floor, in a dark room with extra-maze cues. The rats were handled and habituated to the maze for 10 days. Each trial consisted of a sample run and a choice run, with a delay interval of 15 seconds during the training. For the sample run, two patches of chocolate were placed on each arm of the maze. The rat was forced to enter the left or right arm randomly, by the presence of a block. After a delay interval, on the choice run, the block was removed and the rat was allowed a free choice of either arm. The animal was rewarded by the other chocolate for choosing the opposite arm it had visited before. This was called a correct choice. Rats were run one trial at a time, with an inter-trial interval of 20 minutes. Each daily session consisted of 8 trials. At the end of the training sessions, all animals had reached a >90% correct choice level.

The testing sessions were the same as training sessions, except that the delay interval time was extended from 15 seconds to 4 or 8 minutes. For correlation analysis, the 8 minute delay test was repeated for 3 consecutive days, with a total of 24 trials for each rat. Rats used space rather than response acquisition strategy when the maze was rotated 180° (data not shown). After the T-maze test, blood samples were taken to determine RBC [Mg2+]i.

In the Mg2+ treatment procedure, MgT was administered via the drinking water (50 mg/kg/day elemental Mg2+). This Mg2+ compound was highly bio-affinitive and successfully increased the Mg2+ in rodent brain via dietary supplementation7.

Brain preparation and fluorescent immunostaining

The procedures for brain perfusion, brain fixing, slice cutting, and immunostaining were described before7. Briefly, rats were anesthetized with chloral hydrate, perfused with phosphate buffer saline (PBS), and fixed with 4% paraformaldehyde. Coronal sections (5 μm) from the hippocampus, prefrontal cortex, and striatum were cut on a cryostat (Leica). For immunostaining, the semi-brain slices were blocked in PBS containing 3% rabbit serum (Gibco) and 0.2% TritonX-100. Sections were incubated with mouse anti-synaptophysin antibody (1:500, Millipore) and Alexa 488-coupled rabbit-anti-mouse IgG (1:200, Invitrogen). Mounting medium (Vector Laboratories) was used to prevent fluorescence fading.

Estimation of synaptophysin-positive puncta density

The synapse density could be estimated by immunostaining of synaptophysin (Syn), which binds to the vesicles at the presynaptic release site, and participates in synaptic transmission. Measurement of Syn-(+) puncta can be used for the quantification of synapses. The procedures for confocal scanning and signal processing were described previously7. Briefly, stained brain sections were imaged with an Olympus IX-70 confocal microscope with a 60× water lens at zoom ×3, generating an image of 78.6 × 78.6 μm dimensions. Serial z-sectioning was performed (0.6 μm thick) and the best three z-sections (with the highest number of puncta) were collected and merged into a single image. Therefore, the volume of brain tissue per image was 78.6 × 78.6 × 1.8 μm3. The density of synaptophysin-positive puncta was estimated from the obtained images using Image-Pro-Plus software version 6.0 (Media-Cybernetics). Background levels were equalized and special filters were applied to separate fluorescent puncta. Settings for each image were adjusted to maximize the number of detected fluorescent puncta. The mean punctum number/μm2 was used as an estimate of the presynaptic punctal density.

Statistics

Data are presented as mean ± SD. All data comparing two groups were analyzed using unpaired t tests. Correlations were analyzed using linear regression. The T-maze retention interval curve was analyzed using two-way ANOVA, followed by Bonferroni’s post hoc test. The Mg2+ “on/off” experiment was analyzed using one-way ANOVA, followed by Bonferroni’s post hoc test. Statistical significance was defined as p < 0.05.

Additional Information

How to cite this article: Xiong, W. et al. Erythrocyte intracellular Mg2+ concentration as an index of recognition and memory. Sci. Rep. 6, 26975; doi: 10.1038/srep26975 (2016).

Supplementary Material

Supplementary Information
srep26975-s1.pdf (1,011.8KB, pdf)

Acknowledgments

This work was financially supported by grants from the National Basic Research Program of China (973 Program; 2011CB302201, 2013CB530802) and the National Natural Science Foundation of China (No. 81270425).

Footnotes

Author Contributions W.X. designed and performed the research, analyzed and interpreted data, and drafted the manuscript. Y.L. and X.L. participated in data analysis and figures drawing. G.L. and Z.W. conceived the study, participated in research design and data interpretation, and Z.W. revised the manuscript writing and provided editorial input. All authors read and approved the final manuscript.

References

  1. Jahnen-Dechent W. & Ketteler M. Magnesium basics. Clin Kidney J 5, i3–i14 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Volpe S. L. Magnesium in disease prevention and overall health. Adv Nutr 4, 378S–383S (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. de Baaij J. H., Hoenderop J. G. & Bindels R. J. Magnesium in man: implications for health and disease. Physiol Rev 95, 1–46 (2015). [DOI] [PubMed] [Google Scholar]
  4. Romani A. M. Magnesium in health and disease. Met Ions Life Sci 13, 49–79 (2013). [DOI] [PubMed] [Google Scholar]
  5. Saris N. E., Mervaala E., Karppanen H., Khawaja J. A. & Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294, 1–26 (2000). [DOI] [PubMed] [Google Scholar]
  6. Slutsky I., Sadeghpour S., Li B. & Liu G. Enhancement of synaptic plasticity through chronically reduced Ca2+ flux during uncorrelated activity. Neuron 44, 835–849 (2004). [DOI] [PubMed] [Google Scholar]
  7. Slutsky I. et al. Enhancement of learning and memory by elevating brain magnesium. Neuron 65, 165–177 (2010). [DOI] [PubMed] [Google Scholar]
  8. Barbagallo M., Gupta R. K., Dominguez L. J. & Resnick L. M. Cellular ionic alterations with age: relation to hypertension and diabetes. J Am Geriatr Soc 48, 1111–1116 (2000). [DOI] [PubMed] [Google Scholar]
  9. Barbagallo M., Gupta R. K., Bardicef O., Bardicef M. & Resnick L. M. Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. J Clin Endocrinol Metab 82, 1761–1765 (1997). [DOI] [PubMed] [Google Scholar]
  10. Dominguez L. J., Barbagallo M., Sowers J. R. & Resnick L. M. Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab 83, 4402–4407 (1998). [DOI] [PubMed] [Google Scholar]
  11. Resnick L. M., Gupta R. K. & Laragh J. H. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci USA 81, 6511–6515 (1984). [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Resnick L. M., Gupta R. K., Gruenspan H., Alderman M. H. & Laragh J. H. Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. Am J Hypertens 3, 373–379 (1990). [DOI] [PubMed] [Google Scholar]
  13. Xu X., Hall J., Byles J. & Shi Z. Dietary pattern, serum magnesium, ferritin, C-reactive protein and anaemia among older people. Clinical Nutrition, doi: 10.1016/j.clnu.2015.12.015 (2015). [DOI] [PubMed] [Google Scholar]
  14. Ford E. S. & Mokdad A. H. Dietary magnesium intake in a national sample of US adults. J Nutr 133, 2879–2882 (2003). [DOI] [PubMed] [Google Scholar]
  15. Coudray C., Feillet-Coudray C., Rambeau M., Mazur A. & Rayssiguier Y. Stable isotopes in studies of intestinal absorption, exchangeable pools and mineral status: The example of magnesium. Journal of Trace Elements in Medicine & Biology Organ of the Society for Minerals & Trace Elements 19, 97–103 (2005). [DOI] [PubMed] [Google Scholar]
  16. Alon I. et al. Intracellular magnesium in elderly patients with heart failure: effects of diabetes and renal dysfunction. J Trace Elem Med Biol 20, 221–226 (2006). [DOI] [PubMed] [Google Scholar]
  17. Houillier P. Mechanisms and regulation of renal magnesium transport. Annu Rev Physiol 76, 411–430 (2014). [DOI] [PubMed] [Google Scholar]
  18. Rondón L. J., Groenestege W. M., Rayssiguier Y. & Mazur A. Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine. American Journal of Physiology Regulatory Integrative & Comparative Physiology 294, R2001–R2007 (2008). [DOI] [PubMed] [Google Scholar]
  19. Barbagallo M., Resnick L. M., Dominguez L. J. & Licata G. Diabetes mellitus, hypertension and ageing: the ionic hypothesis of ageing and cardiovascular-metabolic diseases. Diabetes Metab 23, 281–294 (1997). [PubMed] [Google Scholar]
  20. Rotter I. et al. Relationship between serum magnesium concentration and metabolic and hormonal disorders in middle-aged and older men. Magnesium Research Official Organ of the International Society for the Development of Research on Magnesium 28, 99–107 (2015). [DOI] [PubMed] [Google Scholar]
  21. Mario B., Mario B. & Dominguez L. J. Magnesium homeostasis and aging. Magnesium Research Official Organ of the International Society for the Development of Research on Magnesium 22, 235–246 (2009). [DOI] [PubMed] [Google Scholar]
  22. Wei M., Esbaei K., Bargman J. & Oreopoulos D. G. Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 26, 366–373 (2006). [PubMed] [Google Scholar]
  23. Nagel I. E. et al. Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci 2, 1 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Cabeza R., Anderson N. D., Houle S., Mangels J. A. & Nyberg L. Age-related differences in neural activity during item and temporal-order memory retrieval: a positron emission tomography study. J Cogn Neurosci 12, 197–206 (2000). [DOI] [PubMed] [Google Scholar]
  25. Anderson N. D. et al. The effects of divided attention on encoding- and retrieval-related brain activity: A PET study of younger and older adults. J Cogn Neurosci 12, 775–792 (2000). [DOI] [PubMed] [Google Scholar]
  26. Fabiani M. It was the best of times, it was the worst of times: a psychophysiologist’s view of cognitive aging. Psychophysiology 49, 283–304 (2012). [DOI] [PubMed] [Google Scholar]
  27. Barnes C. A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 93, 74–104 (1979). [DOI] [PubMed] [Google Scholar]
  28. Feillet-Coudray C. et al. Magnesium metabolism in mice selected for high and low erythrocyte magnesium levels. Metabolism 53, 660–665 (2004). [DOI] [PubMed] [Google Scholar]
  29. Martindale L. & Heaton F. W. Magnesium deficiency in the adult rat. Biochem J 92, 119–126 (1964). [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Watchorn E. & McCance R. A. Subacute magnesium deficiency in rats. Biochem J 31, 1379–1390 (1937). [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bardgett M. E., Schultheis P. J., McGill D. L., Richmond R. E. & Wagge J. R. Magnesium deficiency impairs fear conditioning in mice. Brain Res 1038, 100–106 (2005). [DOI] [PubMed] [Google Scholar]
  32. Reynolds C. K., Bell M. C. & Sims M. H. Changes in plasma, red blood cell and cerebrospinal fluid mineral concentrations in calves during magnesium depletion followed by repletion with rectally infused magnesium chloride. J Nutr 114, 1334–1341 (1984). [DOI] [PubMed] [Google Scholar]
  33. Feillet-Coudray C., Coudray C., Gueux E., Mazur A. & Rayssiguier Y. A new in vitro blood load test using a magnesium stable isotope for assessment of magnesium status. J Nutr 133, 1220–1223 (2003). [DOI] [PubMed] [Google Scholar]
  34. Kim Y. J. et al. The effects of plasma and brain magnesium concentrations on lidocaine-induced seizures in the rat. Anesth Analg 83, 1223–1228 (1996). [DOI] [PubMed] [Google Scholar]
  35. McKee J. A. et al. Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med 33, 661–666 (2005). [DOI] [PubMed] [Google Scholar]
  36. Masliah E., Mallory M., Hansen L., DeTeresa R. & Terry R. D. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43, 192–197 (1993). [DOI] [PubMed] [Google Scholar]
  37. Dickson D. W. et al. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16, 285–298; discussion 298–304 (1995). [DOI] [PubMed] [Google Scholar]
  38. Smith T. D., Adams M. M., Gallagher M., Morrison J. H. & Rapp P. R. Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. J Neurosci 20, 6587–6593 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sheng-Tian L. et al. Calcineurin plays different roles in group II metabotropic glutamate receptor- and NMDA receptor-dependent long-term depression. Journal of Neuroscience the Official Journal of the Society for Neuroscience 22, 5034–5041 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Izumi Y., Tokuda K. & Zorumski C. F. Long-term potentiation inhibition by low-level N -methyl- D -aspartate receptor activation involves calcineurin, nitric oxide, and p38 mitogen-activated protein kinase. Hippocampus 18, 258–265 (2008). [DOI] [PubMed] [Google Scholar]
  41. Turrigiano G. G. The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135, 422–435 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zhou H. & Liu G. Regulation of density of functional presynaptic terminals by local energy supply. Mol Brain 8, 42 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Deheng W., Jacobs S. A. & Tsien J. Z. Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline. Expert Opinion on Therapeutic Targets 18, 1–10 (2014). [DOI] [PubMed] [Google Scholar]
  44. Yuichiro H. et al. Enhanced stability of hippocampal place representation caused by reduced magnesium block of NMDA receptors in the dentate gyrus. Molecular Brain 7, 1–17 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wilmott L. A. Sex- and dose-dependent effects of post-trial calcium channel blockade by magnesium chloride on memory for inhibitory avoidance conditioning. Behavioural Brain Research 257, 49–53 (2013). [DOI] [PubMed] [Google Scholar]
  46. Billard J. M. Ageing, hippocampal synaptic activity and magnesium. Magnesium Research Official Organ of the International Society for the Development of Research on Magnesium 19, 199–215 (2006). [PubMed] [Google Scholar]
  47. Yin H. H. & Knowlton B. J. Contributions of striatal subregions to place and response learning. Learn Mem 11, 459–463 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Resnick L. M. et al. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 30, 654–659 (1997). [DOI] [PubMed] [Google Scholar]
  49. USDA. The percentages of individuals meeting the dietary reference intakes (DRI). (2007). Available at: http://www.ars.usda.gov/Services/docs.htm?docid=11197
  50. Abernethy M. H. & Fowler R. T. Micellar improvement of the calmagite compleximetric measurement of magnesium in plasma. Clin Chem 28, 520–522 (1982). [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information
srep26975-s1.pdf (1,011.8KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES